Similar articles

• The interplay between ras oncogenes and tumor suppressor genes in experimental carcinogenesis.

  Balmain A, Brown K, Bremner R. Balmain A, et al. Immunol Ser. 1990;51:75-88. Immunol Ser. 1990. PMID: 2128916 Review. No abstract available.
• Altered H1 histamine receptor signaling in Balb/3T3 cells transformed by v-K-ras and v-H-ras oncogenes.

  Blackmore PF, Oakes SG, Somers KD. Blackmore PF, et al. Oncogene. 1992 Oct;7(10):2053-7. Oncogene. 1992. PMID: 1408146
• Malignant transformation by G protein-coupled hormone receptors.

  Sharif M, Sasakawa N, Hanley MR. Sharif M, et al. Mol Cell Endocrinol. 1994 Apr;100(1-2):115-9. doi: 10.1016/0303-7207(94)90289-5. Mol Cell Endocrinol. 1994. PMID: 8056144 Review. No abstract available.
• Reversion and rereversion in ras-transformed cells.

  Marshall CJ. Marshall CJ. Immunol Ser. 1990;51:89-106. Immunol Ser. 1990. PMID: 2128917 Review. No abstract available.
• Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.

  Okazaki M, Kishida S, Murai H, Hinoi T, Kikuchi A. Okazaki M, et al. Cancer Res. 1996 May 15;56(10):2387-92. Cancer Res. 1996. PMID: 8625316